UBS AM’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.81M | Buy |
34,895
+3,498
| +11% | +$333K | ﹤0.01% | 1700 |
|
|
2025
Q4 | $2.55M | Sell |
31,397
-1,600
| -5% | -$138K | ﹤0.01% | 1789 |
|
|
2025
Q3 | $2.89M | Sell |
32,997
-23,372
| -41% | -$2.09M | ﹤0.01% | 1608 |
|
|
2025
Q2 | $4.68M | Buy |
56,369
+18,660
| +49% | +$1.56M | ﹤0.01% | 1743 |
|
|
2025
Q1 | $3.16M | Buy |
37,709
+1,972
| +6% | +$183K | ﹤0.01% | 1789 |
|
|
2024
Q4 | $3.29M | Buy |
35,737
+470
| +1% | +$45.2K | ﹤0.01% | 1809 |
|
|
2024
Q3 | $3.28M | Sell |
35,267
-11,916
| -25% | -$1.03M | ﹤0.01% | 1786 |
|
|
2024
Q2 | $3.88M | Buy |
47,183
+22,508
| +91% | +$1.65M | ﹤0.01% | 1631 |
|
|
2024
Q1 | $1.64M | Hold |
24,675
| – | – | ﹤0.01% | 1774 |
|
|
2023
Q4 | $1.4M | Hold |
24,675
| – | – | ﹤0.01% | 1854 |
|
|
2023
Q3 | $1.34M | Hold |
24,675
| – | – | ﹤0.01% | 1800 |
|
|
2023
Q2 | $1.27M | Hold |
24,675
| – | – | ﹤0.01% | 1888 |
|
|
2023
Q1 | $1.27M | Hold |
24,675
| – | – | ﹤0.01% | 1888 |
|
|
2022
Q4 | $1.14M | Buy |
24,675
+5,482
| +29% | +$257K | ﹤0.01% | 1799 |
|
|
2022
Q3 | $973K | Sell |
19,193
-2,585
| -12% | -$129K | ﹤0.01% | 1984 |
|
|
2022
Q2 | $992K | Buy |
21,778
+3,981
| +22% | +$178K | ﹤0.01% | 1968 |
|
|
2022
Q1 | $827K | Buy |
17,797
+587
| +3% | +$26.3K | ﹤0.01% | 2237 |
|
|
2021
Q4 | $864K | Hold |
17,210
| – | – | ﹤0.01% | 2289 |
|
|
2021
Q3 | $914K | Hold |
17,210
| – | – | ﹤0.01% | 2214 |
|
|
2021
Q2 | $1.05M | Sell |
17,210
-2,588
| -13% | -$137K | ﹤0.01% | 2186 |
|
|
2021
Q1 | $966K | Hold |
19,798
| – | – | ﹤0.01% | 2112 |
|
|
2020
Q4 | $802K | Hold |
19,798
| – | – | ﹤0.01% | 2093 |
|
|
2020
Q3 | $644K | Sell |
19,798
-454
| -2% | -$13.6K | ﹤0.01% | 2017 |
|
|
2020
Q2 | $535K | Buy |
20,252
+9,977
| +97% | +$261K | ﹤0.01% | 2100 |
|
|
2020
Q1 | $256K | Sell |
10,275
-6,301
| -38% | -$195K | ﹤0.01% | 2205 |
|
|
2019
Q4 | $596K | Buy |
16,576
+66
| +0.4% | +$2.28K | ﹤0.01% | 2168 |
|
|
2019
Q3 | $564K | Buy |
16,510
+6,910
| +72% | +$221K | ﹤0.01% | 2232 |
|
|
2019
Q2 | $269K | Hold |
9,600
| – | – | ﹤0.01% | 2448 |
|
|
2019
Q1 | $298K | Hold |
9,600
| – | – | ﹤0.01% | 2321 |
|
|
2018
Q4 | $227K | Hold |
9,600
| – | – | ﹤0.01% | 2337 |
|
|
2018
Q3 | $372K | Hold |
9,600
| – | – | ﹤0.01% | 2204 |
|
|
2018
Q2 | $321K | Hold |
9,600
| – | – | ﹤0.01% | 2269 |
|
|
2018
Q1 | $348K | Buy |
+9,600
| New | +$333K | ﹤0.01% | 2153 |
|
|
2015
Q2 | – | Sell |
-173,926
| Closed | -$1.46M | – | 2712 |
|
|
2015
Q1 | $1.46M | Buy |
+173,926
| New | +$1.36M | ﹤0.01% | 1485 |
|
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
UBS AM's LMAT Position: Q1 2026 in Review
UBS AM increased its LeMaitre Vascular (LMAT) stake by 11% in Q1 2026, buying an estimated $333K and bringing the position to 34,895 shares worth $3.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1700.
UBS AM first reported a position in LMAT in Q1 2015 and has held it in 34 quarters since. The position peaked at $4.68M in Q2 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- UBS AM held 34,895 shares of LeMaitre Vascular worth $3.81M as of Q1 2026.
- UBS AM bought 3,498 LeMaitre Vascular shares in Q1 2026, an estimated $333K.
- LeMaitre Vascular made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #1700 holding.
- UBS AM first reported a position in LeMaitre Vascular in Q1 2015 and has held it in 34 quarters since.
- UBS AM's LeMaitre Vascular position peaked at $4.68M in Q2 2025.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.